Breast cancer liver metastasis: current and future treatment approaches
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Breast cancer liver metastasis: current and future treatment approaches
Authors
Keywords
-
Journal
CLINICAL & EXPERIMENTAL METASTASIS
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-03-06
DOI
10.1007/s10585-021-10080-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer Statistics, 2021
- (2021) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Transcriptional diversity and bioenergetic shift in human breast cancer metastasis revealed by single-cell RNA sequencing
- (2020) Ryan T. Davis et al. NATURE CELL BIOLOGY
- Nano Codelivery of Oxaliplatin and Folinic Acid Achieves Synergistic Chemo-Immunotherapy with 5-Fluorouracil for Colorectal Cancer and Liver Metastasis
- (2020) Jianfeng Guo et al. ACS Nano
- NK1R antagonist decreases inflammation and metastasis of breast carcinoma cells metastasized to liver but not to brain; phenotype-dependent therapeutic and toxic consequences
- (2020) Esra Nizam et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Epidemiology of liver metastases
- (2020) Samantha R Horn et al. Cancer Epidemiology
- Reactivation of BMP signaling by suboptimal concentrations of MEK inhibitor and FK506 reduces organ-specific breast cancer metastasis
- (2020) Jiang Ren et al. CANCER LETTERS
- A Phase Ib study of alpelisib or buparlisib combined with tamoxifen plus goserelin in premenopausal women with HR-positive HER2-negative advanced breast cancer
- (2020) Yen-Shen Lu et al. CLINICAL CANCER RESEARCH
- Proteomic and transcriptomic profiling identifies mediators of anchorage-independent growth and roles of inhibitor of differentiation proteins in invasive lobular carcinoma
- (2020) Nilgun Tasdemir et al. Scientific Reports
- Early Death Incidence and Prediction in Stage IV Breast Cancer
- (2020) Yumei Zhao et al. MEDICAL SCIENCE MONITOR
- Efficacy and Safety of Cyclin-Dependent Kinases 4 and 6 Inhibitors in HR+/HER2− Advanced Breast Cancer
- (2020) Ning Xie et al. Cancer Management and Research
- Characterizations of Cancer Gene Mutations in Chinese Metastatic Breast Cancer Patients
- (2020) Zhonghua Tao et al. Frontiers in Oncology
- FGFR4 regulates tumor subtype differentiation in luminal breast cancer and metastatic disease
- (2020) Susana Garcia-Recio et al. JOURNAL OF CLINICAL INVESTIGATION
- Comparative effectiveness of trastuzumab emtansine versus lapatinib plus capecitabine for HER2+ metastatic breast cancer
- (2020) Sreeram V Ramagopalan et al. Journal of Comparative Effectiveness Research
- Breast Subtypes and Prognosis of Breast Cancer Patients With Initial Bone Metastasis: A Population-Based Study
- (2020) Deyue Liu et al. Frontiers in Oncology
- ER+/HER2+ Breast Cancer Has Different Metastatic Patterns and Better Survival Than ER−/HER2+ Breast Cancer
- (2019) Cletus A. Arciero et al. Clinical Breast Cancer
- Efficacy and Safety of Ribociclib Plus Letrozole in US Patients Enrolled in the MONALEESA-2 Study
- (2019) Denise A. Yardley et al. Clinical Breast Cancer
- OlympiAD final overall survival and tolerability results: Olaparib versus chemotherapy treatment of physician’s choice in patients with a germline BRCA mutation and HER2-negative metastatic breast cancer
- (2019) M E Robson et al. ANNALS OF ONCOLOGY
- Quantitative assessment of breast cancer liver metastasis expansion with patient-derived xenografts
- (2019) Mohammad A. Alzubi et al. CLINICAL & EXPERIMENTAL METASTASIS
- Alpelisib for PIK3CA-Mutated, Hormone Receptor–Positive Advanced Breast Cancer
- (2019) Fabrice André et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and safety of palbociclib plus endocrine therapy in North American women with hormone receptor‐positive/human epidermal growth factor receptor 2‐negative metastatic breast cancer
- (2019) Karen A. Gelmon et al. Breast Journal
- Identification of Alternatively-Activated Pathways between Primary Breast Cancer and Liver Metastatic Cancer Using Microarray Data
- (2019) Wang et al. Genes
- Local Treatment of Breast Cancer Liver Metastasis
- (2019) Reto Bale et al. Cancers
- Breast cancer statistics, 2019
- (2019) Carol E. DeSantis et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Inflammation induced by incomplete radiofrequency ablation accelerates tumor progression and hinders PD-1 immunotherapy
- (2019) Liangrong Shi et al. Nature Communications
- Liver-dominant Breast Cancer Metastasis: A Comparative Outcomes Study of Chemoembolization Versus Radioembolization
- (2018) ANTICANCER RESEARCH
- Combined drug therapeutic strategies for the effective treatment of Triple Negative Breast Cancer
- (2018) Naveen K.R. Chalakur-Ramireddy et al. BIOSCIENCE REPORTS
- Surgical resection versus systemic therapy for breast cancer liver metastases: Results of a European case matched comparison
- (2018) A. Ruiz et al. EUROPEAN JOURNAL OF CANCER
- The role of liver resection in patients with metastatic breast cancer: a systematic review examining the survival impact
- (2018) Sadia Tasleem et al. IRISH JOURNAL OF MEDICAL SCIENCE
- Using patient-derived xenograft models of colorectal liver metastases to predict chemosensitivity
- (2018) Kai M. Brown et al. JOURNAL OF SURGICAL RESEARCH
- Targeting STAT3 to Suppress Systemic Pro-Oncogenic Effects from Hepatic Radiofrequency Ablation
- (2018) Gaurav Kumar et al. RADIOLOGY
- Radiofrequency ablation versus hepatic resection for breast cancer liver metastasis: a systematic review and meta-analysis
- (2018) Yi-bin Xiao et al. Journal of Zhejiang University-SCIENCE B
- Incidence and prognostic factors of patients with synchronous liver metastases upon initial diagnosis of breast cancer: a population-based study
- (2018) Hai-yun Zhao et al. Cancer Management and Research
- Capecitabine in early breast cancer: A meta-analysis of randomised controlled trials
- (2017) Akina Natori et al. EUROPEAN JOURNAL OF CANCER
- Trastuzumab emtansine versus capecitabine plus lapatinib in patients with previously treated HER2-positive advanced breast cancer (EMILIA): a descriptive analysis of final overall survival results from a randomised, open-label, phase 3 trial
- (2017) Véronique Diéras et al. LANCET ONCOLOGY
- Impact of molecular subtypes on metastatic breast cancer patients: a SEER population-based study
- (2017) Yue Gong et al. Scientific Reports
- Hepatic Resection or Ablation for Isolated Breast Cancer Liver Metastasis
- (2016) Eran Sadot et al. ANNALS OF SURGERY
- Biological Subtypes and Distant Relapse Pattern in Breast Cancer Patients After Curative Surgery (Study of Anatolian Society of Medical Oncology)
- (2016) Muhammet A. Kaplan et al. Breast Care
- Yttrium-90 hepatic radioembolization: clinical review and current techniques in interventional radiology and personalized dosimetry
- (2016) Aaron K T Tong et al. BRITISH JOURNAL OF RADIOLOGY
- Vessel co-option is common in human lung metastases and mediates resistance to anti-angiogenic therapy in preclinical lung metastasis models
- (2016) Victoria L Bridgeman et al. JOURNAL OF PATHOLOGY
- Fulvestrant 500 mg versus anastrozole 1 mg for hormone receptor-positive advanced breast cancer (FALCON): an international, randomised, double-blind, phase 3 trial
- (2016) John F R Robertson et al. LANCET
- Identification of liver metastases with probe-based confocal laser endomicroscopy at two excitation wavelengths
- (2016) Crispin Schneider et al. LASERS IN SURGERY AND MEDICINE
- Vessel co-option mediates resistance to anti-angiogenic therapy in liver metastases
- (2016) Sophia Frentzas et al. NATURE MEDICINE
- A Portal Vein Injection Model to Study Liver Metastasis of Breast Cancer
- (2016) Erica T. Goddard et al. Jove-Journal of Visualized Experiments
- SOLTI NeoPARP: a phase II randomized study of two schedules of iniparib plus paclitaxel versus paclitaxel alone as neoadjuvant therapy in patients with triple-negative breast cancer
- (2015) Antonio Llombart-Cussac et al. BREAST CANCER RESEARCH AND TREATMENT
- Breast cancer statistics, 2015: Convergence of incidence rates between black and white women
- (2015) Carol E. DeSantis et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Mechanisms involved in breast cancer liver metastasis
- (2015) Rui Ma et al. Journal of Translational Medicine
- A model of breast cancer heterogeneity reveals vascular mimicry as a driver of metastasis
- (2015) Elvin Wagenblast et al. NATURE
- Phase 2 trial of everolimus and carboplatin combination in patients with triple negative metastatic breast cancer
- (2014) Jasmeet Chadha Singh et al. BREAST CANCER RESEARCH
- Phase III Study of Iniparib Plus Gemcitabine and Carboplatin Versus Gemcitabine and Carboplatin in Patients With Metastatic Triple-Negative Breast Cancer
- (2014) Joyce O'Shaughnessy et al. JOURNAL OF CLINICAL ONCOLOGY
- Treatment of HER2-positive breast cancer
- (2013) Maria Cristina Figueroa-Magalhães et al. BREAST
- A Renewable Tissue Resource of Phenotypically Stable, Biologically and Ethnically Diverse, Patient-Derived Human Breast Cancer Xenograft Models
- (2013) X. Zhang et al. CANCER RESEARCH
- Liver metastases from breast cancer: Surgical resection or not? A case-matched control study in highly selected patients
- (2013) P. Mariani et al. EJSO
- Metastatic progression of breast cancer: insights from 50 years of autopsies
- (2013) Margaret C Cummings et al. JOURNAL OF PATHOLOGY
- Fulvestrant plus anastrozole or placebo versus exemestane alone after progression on non-steroidal aromatase inhibitors in postmenopausal patients with hormone-receptor-positive locally advanced or metastatic breast cancer (SoFEA): a composite, multicentre, phase 3 randomised trial
- (2013) Stephen RD Johnston et al. LANCET ONCOLOGY
- Progression of Ocular Melanoma Metastasis to the Liver
- (2013) Hans E. Grossniklaus JAMA Ophthalmology
- Radiofrequency Ablation of Liver Tumors
- (2013) Debra Gervais et al. SEMINARS IN INTERVENTIONAL RADIOLOGY
- Fulvestrant 500 mg versus anastrozole 1 mg for the first-line treatment of advanced breast cancer: follow-up analysis from the randomized ‘FIRST’ study
- (2012) John F. R. Robertson et al. BREAST CANCER RESEARCH AND TREATMENT
- The histological growth pattern of colorectal cancer liver metastases has prognostic value
- (2012) Gert G. Van den Eynden et al. CLINICAL & EXPERIMENTAL METASTASIS
- FACT: An Open-Label Randomized Phase III Study of Fulvestrant and Anastrozole in Combination Compared With Anastrozole Alone As First-Line Therapy for Patients With Receptor-Positive Postmenopausal Breast Cancer
- (2012) Jonas Bergh et al. JOURNAL OF CLINICAL ONCOLOGY
- Combination Anastrozole and Fulvestrant in Metastatic Breast Cancer
- (2012) Rita S. Mehta et al. NEW ENGLAND JOURNAL OF MEDICINE
- Genomic analysis identifies unique signatures predictive of brain, lung, and liver relapse
- (2011) J. Chuck Harrell et al. BREAST CANCER RESEARCH AND TREATMENT
- Organotropism and prognostic marker discordance in distant metastases of breast carcinoma: fact or fiction? A clinicopathologic analysis
- (2011) Paul St. Romain et al. HUMAN PATHOLOGY
- The seed and soil hypothesis revisited-The role of tumor-stroma interactions in metastasis to different organs
- (2011) Robert R. Langley et al. INTERNATIONAL JOURNAL OF CANCER
- Pertuzumab plus Trastuzumab plus Docetaxel for Metastatic Breast Cancer
- (2011) José Baselga et al. NEW ENGLAND JOURNAL OF MEDICINE
- Redefining the relevance of established cancer cell lines to the study of mechanisms of clinical anti-cancer drug resistance
- (2011) J.-P. Gillet et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Resection of liver metastases from breast cancer: Towards a management guideline
- (2011) Mohammad Howlader et al. International Journal of Surgery
- Metastatic Behavior of Breast Cancer Subtypes
- (2010) Hagen Kennecke et al. JOURNAL OF CLINICAL ONCOLOGY
- Trastuzumab Plus Anastrozole Versus Anastrozole Alone for the Treatment of Postmenopausal Women With Human Epidermal Growth Factor Receptor 2–Positive, Hormone Receptor–Positive Metastatic Breast Cancer: Results From the Randomized Phase III TAnDEM Study
- (2009) Bella Kaufman et al. JOURNAL OF CLINICAL ONCOLOGY
- Hepatic complications of breast cancer
- (2009) Jennifer R Diamond et al. LANCET ONCOLOGY
- Breast Cancer Liver Metastases: US-guided Percutaneous Radiofrequency Ablation—Intermediate and Long-term Survival Rates
- (2009) Maria Franca Meloni et al. RADIOLOGY
- Dangerous halo after neoadjuvant chemotherapy and two-step hepatectomy for colorectal liver metastases
- (2008) G. Mentha et al. BRITISH JOURNAL OF SURGERY
- Subtypes of Breast Cancer Show Preferential Site of Relapse
- (2008) M. Smid et al. CANCER RESEARCH
- Two distinct expression patterns of urokinase, urokinase receptor and plasminogen activator inhibitor-1 in colon cancer liver metastases
- (2008) Martin Illemann et al. INTERNATIONAL JOURNAL OF CANCER
- Phase III Study Comparing Exemestane With Tamoxifen As First-Line Hormonal Treatment of Metastatic Breast Cancer in Postmenopausal Women: The European Organisation for Research and Treatment of Cancer Breast Cancer Cooperative Group
- (2008) Robert J. Paridaens et al. JOURNAL OF CLINICAL ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation